MSU Drug Discovery

Toggle Accessibility Tools



**Next Round of MDG -

Summer 2021**

Check back for RFA


  • "Marley's marvelous success"

  • "The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer" Moerland et al., Scientific Reports, December 2020

  • "Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions" Liu et al., Scientific Reports, October 2020


MSU DD Graphic

Upcoming Events

Sparty head logo
Drug Discovery Seminar Series 


ADDRC logo click

  • High throughput screening
  • Automated laboratory robotics
  • Hit selection

InVivo logo click

  • Efficacy testing in normal & disease models
  • Safety testing
  • Imaging
  • In vivo techical assistance
  • PK studies 


  • Active pharmaceutical ingredient development
  • Screening & target validation
  • Series identification & Scale-up

Other Resources Available:

Molecular Interaction ANalysis